GERMANTOWN, Md., May 15, 2017 /PRNewswire/ -- Intrexon
Corporation (NYSE: XON), a leader in the engineering and
industrialization of biology to improve the quality of life and
health of the planet, today announced management will participate
at the Bank of America Merrill Lynch 2017 Healthcare Conference at
Encore at the Wynn, Las Vegas,
Nevada.
- Andrew Last, Ph.D., Chief
Operating Officer of Intrexon, will present on Tuesday, May 16th, at 5:00 p.m. Pacific Time. A live webcast of
Dr. Last's presentation will be available on the Investors section
of Intrexon's website at http://investors.dna.com/events. A
replay will be available for 30 days following the event.
- Thomas D. Reed, Ph.D., Founder
and Chief Science Officer of Intrexon, will participate in the
panel discussion 'Synthetic Biology, the Promises &
Challenges of Engineering Biology' on Tuesday, May 16th, at 3:00 p.m. Pacific Time.
About Intrexon Corporation:
Intrexon
Corporation (NYSE: XON) is Powering the Bioindustrial Revolution
with Better DNA™ to create biologically-based products that improve
the quality of life and the health of the planet. Intrexon's
integrated technology suite provides its partners across diverse
markets with industrial-scale design and development of complex
biological systems delivering unprecedented control, quality,
function, and performance of living cells. We call our synthetic
biology approach Better DNA®, and we invite you to
discover more at www.dna.com or follow us on Twitter at @Intrexon,
on Facebook, and LinkedIn.
Trademarks
Intrexon, Powering the Bioindustrial
Revolution with Better DNA, and Better DNA are trademarks of
Intrexon and/or its affiliates. Other names may be trademarks of
their respective owners.
Safe Harbor Statement
Some of the statements made in
this press release are forward-looking statements. These
forward-looking statements are based upon our current expectations
and projections about future events and generally relate to our
plans, objectives and expectations for the development of our
business. Although management believes that the plans and
objectives reflected in or suggested by these forward-looking
statements are reasonable, all forward-looking statements involve
risks and uncertainties and actual future results may be materially
different from the plans, objectives and expectations expressed in
this press release.
For more
information regarding Intrexon Corporation, contact:
|
Investor
Contact:
Christopher
Basta
Vice President,
Investor Relations
Tel: +1 (561)
410-7052
investors@intrexon.com
|
Corporate
Contact:
Marie Rossi,
Ph.D.
Director, Technical
Communications
Tel: +1 (301)
556-9850
publicrelations@intrexon.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/intrexon-to-present-at-the-bank-of-america-merrill-lynch-2017-healthcare-conference-300457378.html
SOURCE Intrexon Corporation